Package 51662-1385-1

Brand: naloxone hydrochloride

Generic: naloxone hydrochloride
NDC Package

Package Facts

Identity

Package NDC 51662-1385-1
Digits Only 5166213851
Product NDC 51662-1385
Product ID 51662-1385_11c2f4d2-b965-39b3-e063-6294a90a0836
Description

1 VIAL, MULTI-DOSE in 1 CARTON (51662-1385-1) / 10 mL in 1 VIAL, MULTI-DOSE

Marketing

Marketing Status
Marketed Since 2019-10-15
Brand naloxone hydrochloride
Generic naloxone hydrochloride
Sample Package No

Linked Drug Pages (1)

NALOXONE HYDROCHLORIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "11c2f4d2-b965-39b3-e063-6294a90a0836", "openfda": {"unii": ["F850569PQR"], "rxcui": ["1191222"], "spl_set_id": ["94ff1857-06da-7986-e053-2a95a90afb18"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 CARTON (51662-1385-1)  / 10 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "51662-1385-1", "marketing_start_date": "20191015"}], "brand_name": "NALOXONE HYDROCHLORIDE", "product_id": "51662-1385_11c2f4d2-b965-39b3-e063-6294a90a0836", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "51662-1385", "generic_name": "NALOXONE HYDROCHLORIDE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NALOXONE HYDROCHLORIDE", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": ".4 mg/mL"}], "application_number": "ANDA070257", "marketing_category": "ANDA", "marketing_start_date": "20191015", "listing_expiration_date": "20261231"}